Literature DB >> 19465884

Role of computed tomography perfusion in the evaluation of pancreatic necrosis and pancreatitis after endoscopic ultrasound-guided ablation of the pancreas in a porcine model.

Dushyant V Sahani1, Nagaraj-Setty Holalkere, Avinash Kambadakone, Kai Matthes, Mari Mino-Kenudson, William R Brugge.   

Abstract

OBJECTIVES: To evaluate the role of computed tomography (CT) perfusion in detection of pancreatic necrosis and pancreatitis after endoscopic ultrasound-guided ethanol ablation of porcine pancreas and to correlate the evaluation with histopathology.
METHODS: Under endoscopic ultrasound guidance, 0.9% saline (control) and ethanol at 60%, 80%, and 100% concentrations were injected into the pancreatic tails of 4 pigs. On day 4, dynamic perfusion CT of the pancreas was performed. Perfusion analysis and evaluation of enhancement characteristics were done and correlated with histopathology.
RESULTS: Ethanol injections at 80% and 100% concentrations resulted in focal necrosis surrounded by focal pancreatitis, whereas 60% ethanol injection caused severe focal pancreatitis with microscopic necrosis. The necrotic area revealed reduced blood flow, blood volume, permeability-surface area product, and increased mean transit time compared with pancreatitis and normal tissue (P < or = 0.001). In the control pig, no pancreatitis or necrosis was observed on perfusion images and histopathology.
CONCLUSIONS: Pancreatic necrosis and pancreatitis after ethanol injection reduced the tissue perfusion on CT in comparison to normal tissue, with the changes being more substantial in necrosis than pancreatitis. These findings have possible implications in the accurate detection of pancreatic necrosis in patients with severe pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465884     DOI: 10.1097/MPA.0b013e3181a66fa6

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  7 in total

1.  Perfusion CT is superior to angiography in predicting pancreatic necrosis in patients with severe acute pancreatitis.

Authors:  Yoshihisa Tsuji; Kyoko Hamaguchi; Yuji Watanabe; Akira Okumura; Hiroyoshi Isoda; Naoki Yamamoto; Osamu Kikuchi; Hiroyuki Yamamoto; Kazuhiro Matsueda; Kenji Ueno; Shinsuke Tada; Kaori Togashi; Hiroshi Yamamoto; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2010-07-13       Impact factor: 7.527

2.  CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.

Authors:  Avinash Kambadakone; Sam S Yoon; Tae-Min Kim; Daniel L Karl; Dan G Duda; Thomas F DeLaney; Dushyant V Sahani
Journal:  AJR Am J Roentgenol       Date:  2015-01       Impact factor: 3.959

3.  Protocol modifications for CT perfusion (CTp) examinations of abdomen-pelvic tumors: impact on radiation dose and data processing time.

Authors:  Avinash R Kambadakone; Ashish Sharma; Onofrio A Catalano; Peter F Hahn; Dushyant V Sahani
Journal:  Eur Radiol       Date:  2011-01-19       Impact factor: 5.315

4.  Reproducibility and variability of very low dose hepatic perfusion CT in metastatic liver disease.

Authors:  Osman Melih Topcuoğlu; Muşturay Karçaaltıncaba; Deniz Akata; Mustafa Nasuh Özmen
Journal:  Diagn Interv Radiol       Date:  2016 Nov-Dec       Impact factor: 2.630

5.  Multimodality imaging-guided local injection of eccentric magnetic microcapsules with electromagnetically controlled drug release.

Authors:  Wenwei Huang; Yin Chen; Lanxi Chen; Jinshuang Zhong; Amer M Johri; Jianhua Zhou
Journal:  Cancer Rep (Hoboken)       Date:  2018-12-21

6.  Pancreatic Perfusion CT in Early Stage of Severe Acute Pancreatitis.

Authors:  Yoshihisa Tsuji; Naoki Takahashi; Chiba Tsutomu
Journal:  Int J Inflam       Date:  2012-02-15

7.  Eccentric magnetic microcapsules for MRI-guided local administration and pH-regulated drug release.

Authors:  Jingxian Huang; Wenwei Huang; Yin Chen; Yu Shrike Zhang; Jinshuang Zhong; Yan Li; Jianhua Zhou
Journal:  RSC Adv       Date:  2018-12-17       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.